SCHEMBL323923

SCHEMBL323923

[O]c1cccc(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28129975 0.77 TSHR (0.61)
SCHEMBL713815 0.77
SCHEMBL28140 0.77
Formaldehyde SCHEMBL10275626 0.75 ALDH1A1 (0.52)
Hydrochloric Acid SCHEMBL29273437 0.74 TSHR (0.58)
Bromide SCHEMBL4960063 0.74
Ammonia Solution, Strong SCHEMBL11828318 0.74 TSHR (0.58)
Hydrogen Sulfide SCHEMBL22129212 0.74
SCHEMBL30321461 0.74
Ammonia Solution, Strong SCHEMBL2163448 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140915-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. 2024-05-02 US claimed
US-20240067612-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. 2024-02-29 US claimed
US-20240058284-A1 STAT3 INHIBITORS TVARDI OPERATING COMPANY, INC. 2024-02-22 US claimed
WO-2024010782-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. (US) 2024-01-11 WO claimed
US-20240002344-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR HISTONE LYSINE DEMETHYLASE INHIBITION FIBROGEN, INC. 2024-01-04 US claimed
CN-110305072-B Compounds with phosphodiesterase 4D and acid sphingomyelinase inhibitory activity and uses thereof 中国药科大学 2023-09-19 CN claimed
EP-4204400-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR HISTONE LYSINE DEMETHYLASE INHIBITION Fibrogen, Inc. (US) 2023-07-05 EP claimed
CN-116348450-A Compounds, compositions and methods for histone lysine demethylase inhibition 菲布罗根有限公司 2023-06-27 CN claimed
CN-114409611-A Oxadiazole hydrazide compound and preparation method and application thereof 贵州大学 2022-04-29 CN claimed
CN-113372334-A 2- (4-methionyl) anilino-4-amino-5-trifluoromethylpyrimidine derivatives and application thereof 贵州医科大学 2021-09-10 CN claimed
EP-0054217-A1 Anthraquinone dyes, process for their preparation, their use, as well as liquid-crystal material containing anthraquinone dyes BAYER AG (DE) 1982-06-23 EP claimed
EP-0011928-B1 3,5-DIHYDROXYPENTANOIC ESTER DERIVATIVES HAVING ANTIHYPERLIPAEMIC ACTIVITY, THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1982-04-28 EP claimed
US-4310700-A 1-Hydroxylmethyl-11-deoxy-16-hydroxy-prosten-1-ol-derivatives AMERICAN CYANAMID COMPANY (US) 1982-01-12 US claimed
US-4255444-A ANTICHOLESTEROL AGENTS SANKYO COMPANY LIMITED (JP) 1981-03-10 US claimed
US-4248889-A INHIBITORS OF CHOLESTEROL BIOSYNTHESIS SANKYO COMPANY LIMITED (JP) 1981-02-03 US claimed
US-4241221-A HYPOTENSIVE, ANTIULCER AMERICAN CYANAMID COMPANY (US) 1980-12-23 US claimed
EP-0011928-A1 3,5-Dihydroxypentanoic ester derivatives having antihyperlipaemic activity, their manufacture and pharmaceutical compositions containing them SANKYO COMPANY LIMITED (JP) 1980-06-11 EP claimed
EP-0010951-A1 4-Hydroxy-2-pyrone derivatives, process for their preparation and their pharmaceutical preparations SANKYO COMPANY LIMITED (JP) 1980-05-14 EP claimed
EP-0010360-A1 Prostane derivatives, processes for their preparation and their pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1980-04-30 EP claimed
US-4145540-A ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1979-03-20 US claimed